Nuwellis Updates Investor Presentation, Citing 13% YTD Revenue Growth
Nuwellis updated its investor presentation, reporting 13% YTD revenue growth, 72% gross margin, and a cash runway through Q2 2027. The company highlighted a $4.4B U.S. market opportunity and upcoming product launches, including SmartView and Pressure IQ. Nuwellis also seeks FDA clearance for Aquadex's expanded pediatric use.

